Literature DB >> 25040463

Diarrhoea in general practice: when should a Clostridium difficile infection be considered? Results of a nested case-control study.

M P M Hensgens1, O M Dekkers, A Demeulemeester, A G M Buiting, P Bloembergen, B H B van Benthem, S Le Cessie, E J Kuijper.   

Abstract

Clostridium difficile infections (CDIs) are frequent in hospitals, but also seem to increase in the community. Here, we aim to determine the incidence of CDI in general practice and to evaluate current testing algorithms for CDI. Three Dutch laboratories tested all unformed faeces (12,714) for C. difficile when diagnostic testing (for any enteric pathogen) was requested by a general practitioner (GP). Additionally, a nested case-control study was initiated, including 152 CDI patients and 304 age and sex-matched controls. Patients were compared using weighted multivariable logistic regression. One hundred and ninety-four samples (1.5%) were positive for C. difficile (incidence 0.67/10,000 patient years). This incidence was comparable to that of Salmonella spp. Compared with diarrhoeal controls, CDI was associated with more severe complaints, underlying diseases, antibiotic use and prior hospitalization. In our study, GPs requested a test for C. difficile in 7% of the stool samples, thereby detecting 40% of all CDIs. Dutch national recommendations advise testing for C. difficile when prior antibiotic use or hospitalization is present (18% of samples). If these recommendations were followed, 61% of all CDIs would have been detected. In conclusion, C. difficile is relatively frequent in general practice. Currently, testing for C. difficile is rare and only 40% of CDI in general practice is detected. Following recommendations that are based on traditional risk factors for CDI, would improve detection of CDI.
© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Clostridium difficile infection; community; general practitioner; testing

Mesh:

Year:  2014        PMID: 25040463     DOI: 10.1111/1469-0691.12758

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  16 in total

1.  Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.

Authors:  Elisabeth M Terveer; Monique J T Crobach; Ingrid M J G Sanders; Margreet C Vos; Cees M Verduin; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2016-11-16       Impact factor: 5.948

Review 2.  Clostridium difficile infection.

Authors:  Wiep Klaas Smits; Dena Lyras; D Borden Lacy; Mark H Wilcox; Ed J Kuijper
Journal:  Nat Rev Dis Primers       Date:  2016-04-07       Impact factor: 52.329

Review 3.  Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.

Authors:  Jessica S H Martin; Tanya M Monaghan; Mark H Wilcox
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-03-09       Impact factor: 46.802

Review 4.  Antibacterials Developed to Target a Single Organism: Mechanisms and Frequencies of Reduced Susceptibility to the Novel Anti-Clostridium difficile Compounds Fidaxomicin and LFF571.

Authors:  Jennifer A Leeds
Journal:  Cold Spring Harb Perspect Med       Date:  2016-02-01       Impact factor: 6.915

5.  Prevalence and risk factors for colonization of Clostridium difficile among adults living near livestock farms in the Netherlands.

Authors:  T P Zomer; E VAN Duijkeren; C C H Wielders; C Veenman; P Hengeveld; W VAN DER Hoek; S C DE Greeff; L A M Smit; D J Heederik; C J Yzermans; E J Kuijper; C B M Maassen
Journal:  Epidemiol Infect       Date:  2017-08-14       Impact factor: 4.434

6.  Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factors.

Authors:  Panayiotis D Ziakas; Ioannis M Zacharioudakis; Fainareti N Zervou; Christos Grigoras; Elina Eleftheria Pliakos; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

7.  Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in Internal Medicine: findings from the nationwide FADOI-PRACTICE study.

Authors:  Giorgio Cioni; Pierluigi Viale; Stefania Frasson; Francesco Cipollini; Francesco Menichetti; Nicola Petrosillo; Sergio Brunati; Patrizia Spigaglia; Chiara Vismara; Alessandra Bielli; Fabrizio Barbanti; Giancarlo Landini; Grazia Panigada; Gualberto Gussoni; Erminio Bonizzoni; Giovanni Pietro Gesu
Journal:  BMC Infect Dis       Date:  2016-11-08       Impact factor: 3.090

8.  Ribotype 078 Clostridium difficile infection incidence in Dutch hospitals is not associated with provincial pig farming: Results from a national sentinel surveillance, 2009-2015.

Authors:  Sofie M van Dorp; Sabine C de Greeff; Céline Harmanus; Ingrid M J G Sanders; Olaf M Dekkers; Cornelis W Knetsch; Greetje A Kampinga; Daan W Notermans; Ed J Kuijper
Journal:  PLoS One       Date:  2017-12-29       Impact factor: 3.240

9.  Quantitative Thresholds Enable Accurate Identification of Clostridium difficile Infection by the Luminex xTAG Gastrointestinal Pathogen Panel.

Authors:  Sixto M Leal; Elena B Popowitch; Kara J Levinson; Teny M John; Bethany Lehman; Maria Bueno Rios; Peter H Gilligan; Melissa B Miller
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

10.  Global burden of Clostridium difficile infections: a systematic review and meta-analysis.

Authors:  Evelyn Balsells; Ting Shi; Callum Leese; Iona Lyell; John Burrows; Camilla Wiuff; Harry Campbell; Moe H Kyaw; Harish Nair
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.